User profiles for Stephanie D Davis
Stephanie DavisUNC Verified email at med.unc.edu Cited by 15150 |
[HTML][HTML] An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children
Paul Aurora (Co-chair), Howard Eigen (Co-chair), Hubertus GM Arets, Stephanie D. Davis,
Marcus H. Jones, Janet Stocks, Robert S. Tepper, Daphna Vilozni Summary
Marcus H. Jones, Janet Stocks, Robert S. Tepper, Daphna Vilozni Summary
Bronchopulmonary dysplasia: executive summary of a workshop
…, RH Steinhorn, GG Konduri, SD Davis… - The Journal of …, 2018 - jpeds.com
300 increased to< 90%. 7, 8 More recently, the Canadian Neonatal Network evaluated the
definitions of BPD that were commonly used for epidemiology and clinical trial outcomes for …
definitions of BPD that were commonly used for epidemiology and clinical trial outcomes for …
[HTML][HTML] Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome
Primary ciliary dyskinesia is a genetically heterogeneous disorder of motile cilia. Most of the
disease-causing mutations identified to date involve the heavy (dynein axonemal heavy …
disease-causing mutations identified to date involve the heavy (dynein axonemal heavy …
Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease
MR Knowles, LA Daniels, SD Davis… - American journal of …, 2013 - atsjournals.org
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous recessive disorder of motile
cilia that leads to oto-sino-pulmonary diseases and organ laterality defects in approximately …
cilia that leads to oto-sino-pulmonary diseases and organ laterality defects in approximately …
Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis
D Borowitz, KA Robinson, M Rosenfeld, SD Davis… - The Journal of …, 2009 - Elsevier
Newborn screening for cystic fibrosis (CF) offers the opportunity for early medical and
nutritional intervention that can lead to improved outcomes. Management of the asymptomatic …
nutritional intervention that can lead to improved outcomes. Management of the asymptomatic …
Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review
…, MA Zariwala, T Ferkol, SD Davis… - Pediatric …, 2016 - Wiley Online Library
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, rare lung disease resulting
in chronic oto‐sino‐pulmonary disease in both children and adults. Many physicians …
in chronic oto‐sino‐pulmonary disease in both children and adults. Many physicians …
Diagnosis of primary ciliary dyskinesia. An official American Thoracic Society clinical practice guideline
AJ Shapiro, SD Davis, D Polineni… - American journal of …, 2018 - atsjournals.org
Background: This document presents the American Thoracic Society clinical practice
guidelines for the diagnosis of primary ciliary dyskinesia (PCD). Target Audience: Clinicians …
guidelines for the diagnosis of primary ciliary dyskinesia (PCD). Target Audience: Clinicians …
Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia
Rationale: Several studies suggest that nasal nitric oxide (nNO) measurement could be a
test for primary ciliary dyskinesia (PCD), but the procedure and interpretation have not been …
test for primary ciliary dyskinesia (PCD), but the procedure and interpretation have not been …
Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype
SD Davis, TW Ferkol, M Rosenfeld, HS Lee… - American journal of …, 2015 - atsjournals.org
… Correspondence and requests for reprints should be addressed to Stephanie D. Davis, MD,
Indiana University School of Medicine, Riley Hospital for Children, 705 Riley Hospital Drive, …
Indiana University School of Medicine, Riley Hospital for Children, 705 Riley Hospital Drive, …
Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised …
…, N Bell, S Cunningham, SD Davis… - The lancet Respiratory …, 2013 - thelancet.com
Background Ivacaftor has shown a clinical benefit in patients with cystic fibrosis who have
the G551D-CFTR mutation and reduced lung function. Lung clearance index (LCI) using …
the G551D-CFTR mutation and reduced lung function. Lung clearance index (LCI) using …